New insights into the treatment of CTD-ILD
- PMID: 33408337
- DOI: 10.1038/s41584-020-00567-x
New insights into the treatment of CTD-ILD
References
-
- Juge, P. A. et al. Methotrexate and rheumatoid arthritis associated interstitial lung disease. Eur. Respir. J. 2000337 (2020).
-
- Wells, A. U. et al. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet Respir. Med. 8, 453–460 (2020). - DOI
-
- Khanna, D. et al. Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir. Med. 8, 963–974 (2020). - DOI
-
- Rojas-Serrano, J. et al. Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis. Clin. Rheumatol. 36, 1493–1500 (2017). - DOI
-
- Robles-Pérez, A. et al. A prospective study of lung disease in a cohort of early rheumatoid arthritis patients. Sci. Rep. 10, 15640 (2020). - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
